CD33 and acute myeloid leukemia: BLI analysis of femur, tibia, and spleen of representative mice on day 7, 14, and 21 revealed impeded AML engraftment in CD33-CAR-NK treated animals which was confirmed by flow cytometry analysis of cells isolated from BM and spleen (Fig. 2D).